Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent in combination with graft
Reexamination Certificate
2003-05-24
2008-09-16
Helms, Larry (Department: 1642)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent in combination with graft
C424S198100, C514S002600
Reexamination Certificate
active
07425217
ABSTRACT:
Systems and methods are described providing therapeutic preparations of tachykinins, and more specifically sialokinins, for treating various types of abnormal cellular proliferation conditions in regions of tissue associated with the body of a patient. The sialokinins may be isolated and purified from natural or bioengineered sources, or may be synthesized, and may be combined into, with, or on an implant for local elution or otherwise as a powder mixed in a carrier vehicle for injection delivery. Tumors, warts, and restenosis are abnormal cellular proliferation conditions treated by therapeutic doses of sialokinin. Size of the tissue structure to be treated is used to determine the therapeutic dose of sialokinin. The sialokinins are either locally or systemically delivered at therapeutic doses for the desired effect. Implants such as stents are coated with sialokinins for local elution at the site of injury or tissue otherwise vulnerable to harmful conditions treated by the sialokinin.
REFERENCES:
patent: 5624411 (1997-04-01), Tuch
patent: 7700286 (1997-12-01), Tartagalia et al.
patent: 5763271 (1998-06-01), Ribeiro et al.
patent: 5990125 (1999-11-01), Howard
patent: 6162785 (2000-12-01), Cupp et al.
patent: 6425881 (2002-07-01), Kaesemeyer
patent: WO 95/03036 (1995-02-01), None
patent: WO 98/36784 (1998-08-01), None
Dictionary.com, p. 1-3.
Bhargava et al; BMJ, 2003, 327:274-279.
Dougls (Artherosclerosis Supplements, 2006, 6:47-52).
Paroli et al (Clinical Immunology, 2004, 112:78-84).
Machan (Adv Drug Deliver Rev, 2006, 58:447-462).
Balkwill, F., “The Cytokine Network”, Frontiers in Molecular Biology, Oxford University Press, pp. 37-39, 56-57, 71-73, 178-184, undated.
Meola, S. et al., Isolation and Immunocytochemical Characterization of Three Tachykinin-Related Peptides from the Mosquito,Culex salinarious, Nuerochemical Research, vol. 23, No. 2, 1998, pp. 189-202.
Ribeiro, J. et al., “The Salivary Catechol Oxidase/Peroxidase Activities of the Mosquito Anopheles Albimanus”, J. exp. Biol. 179, pp. 273-287 (1993).
Ribeiro, J. et al., “A Novel Vasodilatory Peptide from the Salivary Glands of the Sand FlyLutzomyia longipalpis”, Science, vol. 243, pp. 212-214, Jan. 13, 1989.
Ribeiro, J. et al., “Salivary Vasodilators ofAedes triseriatusandAnopheles gambia(Diptera: Culicidae)”, Journal of Medical Entomology, vol. 31, No. 5, pp. 747-753, 1994.
Veenstra, J. et al., “Immunohistological localization of regulatory peptides in the midgut of the female mosquitoAedes aegypti”, Histochem Cell Biol (1995) 104:337-347.
Ribeiro, J. et al., “Characterization of a Vasodilator from the Salivary Glands of the Yellow Fever MosquitoAedes aegypti”, J. exp. Biol. 165, 61-72 (1992).
Qureshi, A. et al., “Immunodulatory Properties of Maxadilan: The Vasodilator Peptide from Sand Fly Salivary Gland Extracts”, Am. J. Trop. Med. Hyg. 54(6), 1996, pp. 665-671.
Nassel, D., “Tachykinin-related peptides in invertebrates: a review”, Peptides 20 (1999) 141-158.
Vanden Broeck, J. et al., “Tachykinin-like Peptides and Their Receptors A Review”, Annals New York Academy of Sciences, pp. 374-387, undated.
Brunelleschi, S. et al., “Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors”, source unknown, (1990), 4 pages.
Brunelleschi, S. et al., “Evidence for Tachykinin NK-2B-Like Receptors in Guinea-Pig Alveolar Macrophages”, Life Sciences, vol. 51, pp. PL 177-181- 1992.
Cupp, M. et al., “Vasodilative Activity in Black Fly Salivary Glands”, Am J. Trop. Med. Hyg. 50(2), 1994, pp. 241-246.
Champagne, D. et al., “Sialokinin I and II: Vasodilatory tachykinins from the yellow fever mosquitoAedes aegypti”, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 138-142, Jan. 1994.
Cross, M. et al., “Differential Modulation of Murine Cellular Immune Responses by Salivary Gland Extract ofAedes aegypti”, Am. J. Trop. Med. Hyg. 51(5), 1994, pp. 690-696.
Zeidner, NS et al., “Mosquito feeding modulated Th1 and Th2 cytokines in flavivirus susceptible mice: an effect mimicked by injection of sialokinins, but not demonstrated in flavivirus resistant mice”, Parasite Immunol. Jan. 1999; 21(1):35-44.
Cross, Martin L. et al.; “Differential Modulation Of Murine Cellular Immune Responses By Salivary Gland Extract ofAedes aegypti,” American Journal of Tropical Medicine, vol. 51, No. 51, pp. 690-696, (1994).
Saunders, Nicholas A. et al.; “Simplifying The Molecular Mechanisms Of Human Papillomavirus” Sexually Trasmitted Diseases, vol. 16, No. 4, pp. 823-827, Oct. 1998.
Lundberg, Jan M, “Tachykinins, Sensory Nerves, And Asthma-An Overview,” Can. J. Physiol. Pharmacol., vol. 73, pp. 908-914, (1995).
Hegde, Rashmi S. et al.; “Crystal Structure Of The E2 DNA-Binding Domain From Human Papillomavirus Type 16: Implications For Its DNA Binding-Site Selection Mechanism,” Journal of Molecular Biology, vol. 284, No. 5; pp. 1479-1489, Dec. 1998.
Flaitz, C.M. et al.; “Molecular Piracy: The Viral Link To Carcinogenesis,” Oral Oncology, vol. 34, pp. 448-453, (1998).
Reid, Ted W. et al.; “Stimulation Of Epithelial Cell Growth By The Neuropeptide Substance P,” Journal of Cellular Biochemistry, vol. 52, pp. 476-485, (1993).
Takebayashi, Toru et al.; “Role Of Tachykinins In Airway Reponses To Ozone In Rats,” Journal of Applied Physiology, vol. 85, No. 2, pp. 442-450, (1998).
Noveral, James P. et al.; “Tachykinin Regulation F Airway Smooth Muscle Cell Proliferation,” American Journal of Physiology, vol 269, pp. L339-L343, (1995).
Champagne, Donald E. et al.; “Sialokinin I and II: Vasodilatory Tachykinins From The Yellow Fever MosquitoAedes aegypti,” Pharmacology, vol. 91, pp. 138-142, Jan. 1994.
Klug, William S. et al.; “Chromosome Mutations: Variation In Chromosome Number And Arrangement,” Chapter 10, Concepts of Genetics-Sixth Edition, pp. 251 and pp. 262-263 + cover page, Prentice Hall, Upper Saddle River, New Jersey, (1999).
Palma, C. et al.; “Anti-Tumour Activity Of Tachykinin NK, Receptor Antagonists On Human Glioma U373 MG Xenograft,” British Journal of Cancer, vol. 82, No. 2, pp. 480-487, (2000).
Beerntsen, B.T. et al.; “Characterization of the Sialokinin I Gene Encoding The Salivary Vasocilator Of The Yellow Fever Mosquito,Aedes aegypti,” Insect Molecular Biology, vol. 8, No. 4, pp. 459-467, (1999).
Jarstfer Amiel G.
Maier Nathan C.
Peacock, III James C.
Goddard Laura B
Helms Larry
O'Banion John P.
LandOfFree
System and method for inhibiting cellular proliferation with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with System and method for inhibiting cellular proliferation with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and System and method for inhibiting cellular proliferation with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3968740